Future of Medicine: A Conversation on Cost and Value

May 21, 2014
Washington, DC, District of Columbia

While recent controversies over domestic costs of pharmaceuticals have placed the problem on the national stage, there has ultimately been a failure to produce substantive solutions. Through panels and interviews with healthcare experts across the public and private sectors, The Atlantic and Express Scripts examined whether market-based approaches will work to balance drug prices with critical research and development.

Newseum - Knight Broadcast Studio
555 Pennsylvania Ave, N.W.
Washington, DC 20001
Wednesday, May 21
8:30 am - 12:00 pm

Presented by

Atlantic Live



Working Program Agenda

***Please note that speakers and times are all subject to change

8:40 am   Welcome Remarks

  • The Atlantic

8:45 am      Hepatitis C: A Brief Medical Primer

  • Rena Fox, Professor of Medicine, UCSF @UCSF

8:50 am      Tipping Point: The Unprecedented Hepatitis C Situation

Moderated By:  James Hamblin, Senior Editor, The Atlantic @jameshamblin

  • Richard Elion, Clinical Research Director, Whitman-Walker Health @whitmanwalker
  • Rena Fox, Professor of Medicine, UCSF @UCSF
  • Donald Jensen, Director of the Center for Liver Diseases, University of Chicago @DonaldJensenMD
  • Steven Pearson, President, Institute for Clinical and Economic Review; Visiting Scientist, Department of Bioethics, National Institutes of Health @icer_review

9:30 am      Keynote Interview

Moderated By:  Matt Cooper, Contributing Editor, Newsweek @mattizcoop

  • The Honorable Diana DeGette, D-CO, United States House of Representatives @RepDianaDeGette

9:45 am      Surveying the Pipeline: Pricing Future Pharmaceutical Innovation

Moderated By:  Sarah Kliff, Senior Editor, Vox @sarahkliff

  • Alan Coukell, Senior Director, Drugs and Medical Devices, Pew Charitable Trusts @coukell
  • Sharon Levine, Associate Executive Medical Director, The Permanente Group @KPShare
  • Sara Radcliffe, Executive Vice President for Health, Biotechnology Industry Organization @IAmBiotech

10:30 am    Keynote Interview

Moderated By:  Olga Khazan, Associate Editor, The Atlantic @olgakhazan

  • Daniel Bahr, Visiting Senior Fellow, Center for American Progress; former Federal Minister of Health, Germany @danielbahr

10:45 am    Can the Market Help?

Moderated By:  Matt Cooper, Contributing Editor, Newsweek @mattizcoop

  • John Castellani, President and Chief Executive Officer, PhRMA @PhRMA
  • Karen Ignagni, President and Chief Executive Officer, America’s Health Insurance Plans @AHIPCoverage
  • Brian Marcotte, President, National Business Group on Health @NBGHemployers
  • Steve Miller, Senior Vice President and Chief Medical Officer, Express Scripts @ExpressScripts
  • Kirsten Axelsen, Vice President of Worldwide Policy, Pfizer @pfizer

11:35 am     Achieving Access and Communications Value to Patients in a Complex Health Care System

Moderated By:  Steve Clemons, Washington Editor-at-Large, The Atlantic @scclemons

  • Matt DeCamp, Assistant Professor of Bioethics, Johns Hopkins University @JohnsHopkins
  • Joxel Garcia, Director, Department of Health, District of Columbia
  • Lowell Schnipper, Clinical Director of Hematology and Oncology, Beth Israel Deaconness Medical Center @BIDMChealth
  • Lisa Scholz, Chief Operating Officer and Chief Pharmacy Officer, Safety Net Hospitals for Pharmaceutical Access @SNHPA

12:10 pm  Closing Remarks


Presenting Level

Supporting Level

Upcoming Events

  • Economy/Business

    Atlantic Exchange featuring Lord Adair Turner

    Our series of interviews with disruptive innovators and consequential political, community and business leaders continued with a discussion featuring Lord Adair Turner.

  • The Atlantic Housing for Tomorrow Forum

    The Atlantic will convene a public forum to discuss whether a new kind of housing bubble is starting to simmer and what options are emerging to address this growing urgency for many Americans.

  • Technology


    The Atlantic and the USC Annenberg School for Communication and Journalism will host an event exploring the merging of Hollywood and Silicon Valley and how the new dynamics are redefining the entertainment industry.